Charles A Peloquin Selected Research

Ethambutol (Myambutol)

1/2018	Protein Binding of First-Line Antituberculosis Drugs.
1/2018	Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children: Adequacy of Revised Dosages of TB Drugs for Children.
1/2018	Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations.
1/2017	Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection.
8/2012	Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
6/2009	Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
12/2005	The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles A Peloquin Research Topics

Disease

81	Tuberculosis (Tuberculoses) 06/2022 - 01/2002
27	Infections 01/2022 - 06/2004
19	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 06/2022 - 08/2006
17	Pulmonary Tuberculosis 12/2021 - 01/2002
14	HIV Infections (HIV Infection) 01/2021 - 05/2005
9	Body Weight (Weight, Body) 01/2020 - 06/2002
7	Critical Illness (Critically Ill) 01/2022 - 08/2003
5	Meningeal Tuberculosis (Tuberculous Meningitis) 09/2022 - 04/2015
5	Invasive Fungal Infections 01/2017 - 01/2013
3	Inflammation (Inflammations) 01/2022 - 11/2008
3	Coinfection 01/2021 - 01/2019
3	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2020
3	Latent Tuberculosis 10/2016 - 04/2014
3	Communicable Diseases (Infectious Diseases) 10/2016 - 01/2002
3	Mycoses (Diseases, Fungus) 01/2016 - 08/2008
2	Seizures (Absence Seizure) 01/2022 - 06/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2021
2	Extensively Drug-Resistant Tuberculosis 01/2021 - 06/2014
2	Liver Diseases (Liver Disease) 07/2014 - 10/2006
2	Granuloma 08/2013 - 08/2012
2	Lung Diseases (Lung Disease) 09/2012 - 08/2008
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Ventilator-Associated Pneumonia 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Gram-Negative Bacterial Infections 09/2021
1	Meningitis 06/2021
1	Sepsis (Septicemia) 06/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Cross Infection (Nosocomial Infection) 10/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Immune Reconstitution Inflammatory Syndrome 02/2017

Drug/Important Bio-Agent (IBA)

56	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
34	Rifampin (Rifampicin)FDA LinkGeneric 06/2022 - 09/2002
25	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018 - 09/2002
19	Pyrazinamide FDA LinkGeneric 06/2022 - 06/2002
15	Linezolid (Zyvox)FDA Link 09/2022 - 08/2003
15	rifapentine (Priftin)FDA Link 10/2017 - 05/2003
10	Moxifloxacin (Avelox)FDA Link 03/2019 - 12/2005
9	Levofloxacin (Levaquin)FDA Link 01/2019 - 03/2008
9	RifamycinsIBA 10/2017 - 08/2003
7	Ethambutol (Myambutol)FDA LinkGeneric 01/2018 - 12/2005
6	FluoroquinolonesIBA 06/2022 - 04/2011
6	AerosolsIBA 08/2013 - 04/2009
6	Rifabutin (Ansamycin)FDA Link 11/2009 - 08/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2009
5	Voriconazole (Vfend)FDA LinkGeneric 01/2017 - 08/2008
4	Clofazimine (Lamprene)FDA Link 06/2022 - 01/2018
4	pretomanidIBA 12/2011 - 08/2006
3	Cefepime (Maxipime)FDA LinkGeneric 01/2022 - 01/2020
3	bedaquiline (R207910)IBA 12/2021 - 12/2011
3	posizolidIBA 01/2018 - 11/2016
3	Drug CombinationsIBA 08/2013 - 03/2011
3	Vancomycin FDA LinkGeneric 10/2007 - 10/2003
2	Cycloserine (Seromycin)FDA Link 09/2022 - 01/2019
2	EnzymesIBA 01/2022 - 07/2014
2	beta-LactamsIBA 01/2022 - 09/2021
2	OPC-67683IBA 12/2021 - 10/2019
2	AcidsIBA 01/2021 - 01/2017
2	Nevirapine (Viramune)FDA Link 01/2021 - 10/2019
2	Lamivudine (Epivir)FDA Link 01/2021 - 01/2020
2	efavirenz (Sustiva)FDA Link 01/2019 - 11/2005
2	Cytochrome P-450 CYP2C19IBA 01/2017 - 07/2014
2	Amikacin (A.M.K)FDA LinkGeneric 01/2017 - 06/2004
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 10/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2014 - 11/2005
2	posaconazole FDA Link 01/2013 - 09/2012
2	Dihydrotachysterol (AT 10)IBA 09/2012 - 07/2012
2	Streptomycin (Streptomycin Sulfate)FDA Link 10/2010 - 06/2004
2	PowdersIBA 08/2009 - 04/2009
1	Vigabatrin FDA Link 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Antitubercular AgentsIBA 12/2021
1	beta Lactam AntibioticsIBA 09/2021
1	Reverse Transcriptase InhibitorsIBA 01/2021
1	NucleosidesIBA 01/2021
1	abacavir (Ziagen)FDA Link 01/2021
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2021
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	Isonicotinic Acids (Isonicotinic Acid)IBA 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020
1	Losartan (Cozaar)FDA LinkGeneric 01/2020
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2020
1	Ethionamide (Trecator-SC)FDA Link 01/2020
1	Tenofovir (Viread)FDA Link 01/2020
1	TabletsIBA 01/2020
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 10/2019
1	Verapamil (Calan)FDA LinkGeneric 01/2018
1	OxindolesIBA 10/2017
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2017

Therapy/Procedure

37	Therapeutics 01/2022 - 05/2003
6	Duration of Therapy 01/2021 - 08/2006
4	Continuous Renal Replacement Therapy 01/2022 - 08/2003
3	Drug Therapy (Chemotherapy) 11/2016 - 01/2002
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Art Therapy 10/2019